Antony C. Mattessich, President and CEO at OCULAR THERAPEUTIX, INC (OCUL), sold 39,338 shares at $4.24 ($167K) on 2023-02-06, disclosed to the SEC on 2023-02-08.
Open-market sale of $167k OCUL by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.24 | 19,669 | $83K | 50.0% |
| 2 | $4.24 | 19,669 | $83K | 50.0% |
| Total | $4.24 avg | 39,338 | $167K | 100% |
| Filing → |
| OCUL | BUY | 2023-09-05 | $25K | — | Filing → |
| OCUL | BUY | 2021-08-24 | $49K | — | Filing → |
| OCUL | BUY | 2019-06-10 | $112K | — | Filing → |